(Q48521127)

12 February 2018

title

Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report. (English)

1 reference

12 February 2018

1 reference

1 reference

3

Odaimi M

0 references

author name string

Lederman G

1

1 reference

12 February 2018

Arbit E

2

1 reference

12 February 2018

Lombardi E

4

1 reference

12 February 2018

Wrzolek M

5

1 reference

12 February 2018

Wronski M

6

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

12 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

12 February 2018

volume

40

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

661-666

1 reference

12 February 2018

Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

The role of chemotherapy in recurrent malignant gliomas: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Reoperation in the treatment of recurrent intracranial malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Radiosurgery: a new application?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Fractionated stereotactic radiation therapy for intracranial tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Long-term follow-up of gliomas treated with fractionated stereotactic irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Grading of astrocytomas. A simple and reproducible method.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

High activity iodine-125 interstitial implant for gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Radiosurgery as part of the initial management of patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Stereotactic radiosurgery for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Stereotactic radiosurgery for recurrent gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

A non-invasive, relocatable stereotactic frame for fractionated radiotherapy and multiple imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Salvage chemotherapy with paclitaxel for recurrent primary brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Paclitaxel (Taxol) concentrations in brain tumor tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

Phase II study of paclitaxel in patients with recurrent malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900843-2

7 January 2021

10.1016/S0360-3016(97)00843-2

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018